A Narrative Review on Measurement Properties of Fixed-distance Walk Tests Up to 40 Meters for Adults With Knee Osteoarthritis.
Hiral MasterGrace ColemanFiona DobsonKim Louise BennellRana Shane HinmanJason T JakielaDaniel Kenta WhitePublished in: The Journal of rheumatology (2020)
Knee osteoarthritis (OA) is a serious disease and has no cure to date. Knee OA is a leading cause of functional limitation (e.g., difficulty walking). Walking speed is 1 method of quantifying difficulty with walking and should be assessed in clinical practice for adults with knee OA because it has prognostic value and is modifiable. Specifically, slow walking speed is associated with increased risk of adverse health outcomes, including all-cause mortality in adults with knee OA and can be modified by engaging in physical activity or exercise. However, at present, there is little consensus on the distance and instructions used to conduct the walk test. Distance is often selected based on space availability, and instruction varies, from asking the participants to walk at a comfortable pace versus as fast as possible. Therefore, the purpose of this narrative review is to summarize the measurement properties, strengths, and limitations of a fixed-distance walk test ≤ 40 meters in adults with knee OA. Good measurement properties in terms of reliability and validity were observed across the different testing protocols for fixed-distance walk test (i.e., any distance ≤ 40 m and fast- or self-paced). Therefore, clinicians and researchers can select a testing protocol that can safely and consistently be performed over time, as well as provide a practice trial to acclimatize the patients to the fixed-distance walk test.
Keyphrases
- knee osteoarthritis
- physical activity
- clinical practice
- end stage renal disease
- healthcare
- clinical trial
- randomized controlled trial
- total knee arthroplasty
- lower limb
- primary care
- chronic kidney disease
- newly diagnosed
- study protocol
- peritoneal dialysis
- phase ii
- quality improvement
- patient reported outcomes
- open label